See Shionogi-Sponsored Publications

Publications

Here, you can review available Shionogi-sponsored publications. If you would like an electronic copy of one of the journal publications on this page, please contact
Shionogi Medical Information for further assistance.

Looking for a specific publication? Use the Search feature above to find content by keyword, author, title, disease state, medicine, or compound. Please note that Search functions site-wide and will take you to a separate results page.

Information about investigational compounds or investigational uses of products does not imply FDA approval of these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the investigational compounds or investigational uses of products will receive FDA approval. Shionogi does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.

  • All
  • Cefiderocol
  • Edaravone
  • Ensitrelvir
  • Zatolmilast
  • All
  • In vitro
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • Real-world evidence
  • Surveillance
  • Review
  • Pharmacokinetics/Pharmaco-dynamics
  • Compatibility
  • All
  • Amyotrophic Lateral Sclerosis (ALS)
  • COVID-19
  • Fragile X syndrome
  • Gram-negative infection
 
Cefiderocol
Review
Gram-negative infection

Antimicrobial snapshot: cefiderocol

Published:
2026
Authors:
Nguyen ST, Simon S, DeJonge BLM.
View Publication
 
Cefiderocol
Real-world evidence
Gram-negative infection

Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes 

Published:
2026
Authors:
Cantón R, García-Castillo M, Hernández-García M, et al.
View Publication
 
Review
COVID-19

Current impact of COVID-19 in long-term care facilities in the United States: a systematic literature review

Published:
2026
Authors:
Gravenstein S, Cooke CE, Verdi D, et al.
View Publication
 
Ensitrelvir
Pharmacokinetics/Pharmacodynamics
COVID-19

Effects of ensitrelvir on the pharmacokinetics of combined oral contraceptives (ethinyl estradiol/drospirenone) in healthy adult women: a phase 1 fixed-sequence, multiple-dose, drug–drug interaction study

Published:
2026
Authors:
Shimizu R, Shibata RY, Kubota R, et al.
View Publication
 
Ensitrelvir
Phase 3
COVID-19

Ensitrelvir for COVID-19 postexposure prophylaxis in household contacts 

Published:
2026
Authors:
Hayden FG, Shinkai M, Clark TW, et al.
View Publication